Merck & Co., Inc. Names Michael J. Holston As Future General Counsel; Will Succeed Bruce N. Kuhlik In July 2015

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the future appointment of Michael J. Holston as general counsel, effective July 01, 2015. Holston, who will also oversee responsibility for Merck’s communications, policy and security organizations beginning July 1 of this year, will succeed Bruce N. Kuhlik upon his retirement after ten years with the company. Holston will remain in his role as chief ethics and compliance officer during the transition period. These changes reflect a multi-year executive succession planning process.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC